Michael Menden is a Junior Group Leader at the Institute of Computational Biology (ICB), Helmholtz Zentrum München since 2019. Michael's PhD was awarded by the University of Cambridge in 2016, and he became an ERC StG laureate in 2020. His research interest is computational pharmacogenomics including drug target identification, drug repositioning and patient stratification empowering personalised medicine.